Medtronic Blood Management

Hemostasis Management

HMS Plus Hemostasis Management System is used to perform multiple tests for heparin management. It provides an individual patient’s dose response to heparin so that the needed anticoagulant and antithrombotic effect can be achieved. Hemostasis management can result in fewer complication associated with excessive blood loss,¹ preservation of the coagulation system resulting in fewer transfusion,² and fewer surgical reoperations, thus decreasing associated costs.³

The ACT Plus^® Plus combines the trusted standard in precise clot detection technology with data management and connectivity-ready capabilities. Unlike algorithm-based test measurement, the ACT Plus System provides real-time clot detection, ensuring accurate and precise clotting time results. 

Autotransfusion

The autoLog® Autotransfusion System is a sophisticated and effective processing system with a fully automated design. It consistently produces a high-quality end product that offers simplicity of operation and elimination of operator variability.

Platelet Therapy

More surgery teams are using the original technology of the Magellan^® Autologous Platelet Separator System to harness the platelets. Designed with input from experts in autologous blood component utilization, this lightweight, portable, closed-system separator requires only a small amount of a patient's blood and delivers consistent, platelet-rich plasma regardless of operator or patient variability. User flexibility allows the clinician to customize the platelet concentration in order to meet changing requirements.

1. Hill, AG, et al. More precise heparin and protamine management during cardiopulmonary bypass. Proceedings of the American Academy of Cardiovascular Perfusion. 1990;12-16.
2. Despotis, GJ, et al. More effective suppression of hemostasis system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost. 1996;67:2-8.
3. Despotis, GJ, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. J Thorac Cardiovascular Surg. 1995;110:46-54.